WESTMINSTER — ARCA biopharma Inc. (NYSE: ABIO) has received approval from regulatory authorities to begin testing its COVID-19 treatment drug […]
Source: BizWest
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
WESTMINSTER — Gene therapy maker ARCA biopharma Inc. (Nasdaq: ABIO) has filed an initial application to study whether its anti-blood…
BOULDER — At the end of the first quarter of 2023, a period in which Arca Biopharma Inc. (Nasdaq: ABIO)…
WESTMINSTER — Arca biopharma Inc. (Nasdaq: ABIO) restructured a stock sale-on-demand agreement with a major creditor as it prepares to…
WESTMINSTER — ARCA Biopharma Inc. (Nasdaq: ABIO) “will need to raise additional capital and/or complete a partnership or other possible…
